换一批Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
第一作者：
Attilio,Olivieri
第一单位：
Clinica di Ematologia, Università Politecnica delle Marche, Ancona, Italy;
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);自身抗体(Autoantibodies);苯甲酰胺类(Benzamides);慢性病(Chronic Disease);无病生存(Disease-Free Survival);女(雌)性(Female);随访研究(Follow-Up Studies);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);淋巴组织增殖性疾病(Lymphoproliferative Disorders);男(雄)性(Male);中年人(Middle Aged);监测, 生理学(Monitoring, Physiologic);骨髓增殖性疾病(Myeloproliferative Disorders);哌嗪类(Piperazines);泼尼松龙(Prednisolone);前瞻性研究(Prospective Studies);蛋白激酶抑制剂(Protein Kinase Inhibitors);嘧啶类(Pyrimidines);受体, 血小板源生长因子(Receptors, Platelet-Derived Growth Factor);疾病严重程度指数(Severity of Illness Index);存活率(Survival Rate);时间因素(Time Factors)
DOI
10.1182/blood-2013-05-494278
PMID
24152907
发布时间
2021-02-02
- 浏览16
Blood
4111-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
